Загрузка...
Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
Rapamycin is a Food and Drug Administration (FDA)-approved immunosuppressant and anticancer agent discovered in the soil of Easter Island in the early 1970s. Rapamycin is a potent and selective inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase, which acts as a central integrator...
Сохранить в:
| Опубликовано в: : | Cold Spring Harb Perspect Med |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cold Spring Harbor Laboratory Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4852795/ https://ncbi.nlm.nih.gov/pubmed/27048303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a025924 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|